Viking Therapeutics, Inc. is a biotechnology company focused on developing therapies for obesity and metabolic diseases. The company engages in drug development and commercialization, leveraging expertise in science and finance. Its leadership team has experience in advancing therapies through various stages, including discovery and regulatory approval. Viking Therapeutics operates primarily in the biopharmaceutical sector, targeting patients with metabolic disorders.
- Website
- vikingtherapeutics.com
- Issuer profile
- All listings